Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251

Virology

Volumn 386, Issue 1, 2009, Pages 109-121

  Dubie, Robert A ^a   Maksaereekul, Saipiroon ^a   Shacklett, Barbara L ^b   Lemongello, Donna ^b   Cole, Kelly S ^c   Villinger, Francois ^d   Blozis, Shelley A ^a   Luciw, Paul A ^a   Sparger, Ellen E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA vaccine; Interleukin 15; SIV; vif

Indexed keywords

DNA VACCINE; GAG PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; NEF PROTEIN; POL PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; TISSUE PLASMINOGEN ACTIVATOR; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ACTIVE IMMUNIZATION; ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE DELETION; GENE PRODUCTS, VIF; INTERFERON-GAMMA; INTERLEUKIN-15; MACACA MULATTA; PLASMIDS; PROVIRUSES; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VACCINES, DNA; VIRAL LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 61849154036     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.01.007     Document Type: Article

References (64)

1. Abel K., Compton L., Rourke T., Montefiori D., Lu D., Rothaeusler K., Fritts L., Bost K., and Miller C.J. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J. Virol. 77 (2003) 3099-3118
2. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., Asher T.E., Samri A., Schnuriger A., Theodorou I., Costagliola D., Rouzioux C., Agut H., Marcelin A.G., Douek D., Autran B., and Appay V. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204 (2007) 2473-2485
3. Becker T.C., Wherry E.J., Boone D., Murali-Krishna K., Antia R., Ma A., and Ahmed R. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195 (2002) 1541-1542
4. Boyer J.D., Robinson T.M., Kutzler M.A., Vansant G., Hokey D.A., Kumar S., Parkinson R., Wu L., Sidhu M.K., Pavlakis G.N., Felber B.K., Brown C., Silvera P., Lewis M.G., Monforte J., Waldmann T.A., Eldridge J., and Weiner D.B. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 18648-18653
5. Calarota S.A., and Weiner D.B. Approaches for the design and evaluation of HIV-1 DNA vaccines. Exp. Rev. Vaccines 3 (2004) S135-S149
6. Catanzaro A.T., Roederer M., Koup R.A., Bailer R.T., Enama M.E., Nason M.C., Martin J.E., Rucker S., Andrews C.A., Gomez P.L., Mascola J.R., J. N.G., Graham B.S., and Team V.S. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. Vaccine 25 (2007) 4085-4092
7. Chiu Y.L., and Greene W.C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26 (2008) 317-353
8. Chong S.Y., Egan M.A., Kutzler M.A., Megati S., Masood A., Roopchard V., Garcia-Hand D., Montefiori D.C., Quiroz J., Rosati M., Schadeck E.B., Boyer J.D., Pavlakis G.N., Weiner D.B., Sidhu M.K., Eldridge J.H., and Israel Z.R. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 25 (2007) 4967-4982
9. Cole K.S., Rowles J.L., Jagerski B.A., Murphey-Corb M., Unangst T., Clements J.E., Robinson J., Wyand M.S., Desrosiers R.C., and Montelaro R.C. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71 (1997) 5069-5079
10. Demberg, T., Boyer, J.D., Malkevich, N., Patterson, L.J., Venzon, D., Summers, E.L., Kalisz, I., Kalyanaraman, V.S., Lee, E.M., Weiner, D.B., Robert-Guroff, M., 2008. Sequential priming with SIV DNA vaccines, with or without encoded cytokines, and a replicating Ad-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge. J. Virol. 82, 10911-10921.
11. Desrosiers R.C., Lifson J.D., Gibbs J.S., Czajak S.C., Howe A.Y., Arthur L.O., and Johnson R.P. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72 (1998) 1431-1437
12. Duvall M.G., Precopio M.L., Ambrozak D.A., Jaye A., McMichael A.J., Whittle H.C., Roederer M., Rowland-Jones S.L., and Koup R.A. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38 (2008) 350-363
13. Feinberg M.B., and Moore J.P. AIDS vaccine models: challenging challenge viruses. Nat. Med. 8 (2002) 207-210
14. Genescà M., Rourke T., Li J., Bost K., Chohan B., McChesney M.B., and Miller C.J. Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239. J. Immunol. 179 (2007) 4732-4740
15. Gupta S., Leutenegger C.M., Dean G.A., Steckbeck J.D., Cole K.S., and Sparger E.E. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon. J. Virol. 81 (2007) 465-473
16. Halwani R., Boyer J.D., Yassine-Diab B., Haddad E.K., Robinson T.M., Kumar S., Parkinson R., Wu L., Sidhu M.K., Phillipson-Weiner R., Pavlakis G.N., Felber B.K., Lewis M.G., Shen A., Siliciano R.F., Weiner D.B., and Sekaly R.P. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA+IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. J. Immunol. 180 (2008) 7969-7979
17. Harari A., Cellerai C., Enders F.B., Köstler J., Codarri L., Tapia G., Boyman O., Castro E., Gaudieri S., James I., John M., Wagner R., Mallal S., and Pantaleo G. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 16233-16238
18. Harmache A., Russo P., Guiguen F., Vitu C., Vignoni M., Bouyac M., Hieblot C., Pepin M., Vigne R., and Suzan M. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 224 (1996) 246-255
19. Hokey D.A., and Weiner D.B. DNA vaccines for HIV: challenges and opportunities. Springer Semin. Immunopathol. 28 (2006) 267-279
20. Hryniewicz A., Price D.A., Moniuszko M., Boasso A., Edghill-Spano Y., West S.M., Venzon D., Vaccari M., Tsai W.P., Tryniszewska E., Nacsa J., Villinger F., Ansari A.A., Trindade C.J., Morre M., Brooks D., Arlen P., Brown H.J., Kitchen C.M., Zack J.A., Douek D.C., Shearer G.M., Lewis M.G., Koup R.A., and Franchini G. Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J. Immunol. 178 (2007) 3492-3504
21. Jalah R., Rosati M., Kulkarni V., Patel V., Bergamaschi C., Valentin A., Zhang G.M., Sidhu M.K., Eldridge J.H., Weiner D.B., Pavlakis G.N., and Felber B.K. Efficient systemic expression of bioactive IL-15 in mice upon delivery of optimized DNA expression plasmids. DNA Cell Biol. 26 (2007) 827-840
22. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., Irwin C.E., Safrit J.T., Mittler J., Weinberger L., Kostrikis L.G., Zhang L., Perelson A.S., and Ho D.D. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189 (1999) 991-998
23. Kutzler M.A., Robinson T.M., Chattergoon M.A., Choo D.K., Choo A.Y., Choe P.Y., Ramanathan M.P., Parkinson R., Kudchodkar S., Tamura Y., Sidhu M., Roopchand V., Kim J.J., Pavlakis G.N., Felber B.K., Waldmann T.A., Boyer J.D., and Weiner D.B. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J. Immunol. 175 (2005) 112-123
24. Kwissa M., Amara R.R., Robinson H.L., Moss B., Alkan S., Jabbar A., Villinger F., and Pulendran B. Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J. Exp. Med. 204 (2007) 2733-2746
25. Larsson M., Jin X., Ramratnam B., Ogg G.S., Engelmayer J., Demoitie M.A., McMichael A.J., Cox W.I., Steinman R.M., Nixon D., and Bhardwaj N. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13 (1999) 767-777
26. Lena P., Villinger F., Giavedoni L., Miller C.J., Rhodes G., and Luciw P. Co-immunization of rhesus macaques with plasmid vectors expressing IFN-gamma, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus. Vaccine 20 Suppl. 4 (2002) A69-A79
27. Letvin N.L. Progress and obstacles in the development of an AIDS vaccine. Nat. Rev., Immunol. 6 (2006) 930-939
28. Letvin N.L. Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 27 (2007) 366-369
29. Leutenegger C.M., Higgins J., Matthews T., Tarantal A.F., Luciw P.A., Pedersen N.C., and North T.W. Real-time TaqMan® PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res. Hum. Retrovir. 17 (2001) 243-251
30. Lin S.J., Cheng P.J., Hsiao S.S., Lin H.H., Hung P.F., and Kuo M.L. Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin-activated umbilical cord blood T cells. Am. J. Hematol. 80 (2005) 106-112
31. Lockridge K., Chien M., Luciw P.A., and Sparger E.E. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Virology 273 (2000) 67-79
32. Lori F., Weiner D.B., Calarota S.A., Kelly L.M., and Lisziewicz J. Cytokine-adjuvanted HIV-DNA vaccination strategies. Springer Semin. Immunopathol. 28 (2006) 231-238
33. Ma Z.M., Abel K., Rourke T., Wang Y., and Miller C.J. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J. Virol. 78 (2004) 14048-14052
34. Makedonas G., and Betts M.R. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin. Immunopathol. 28 (2006) 209-219
35. McChesney M.B., Collins J.R., Lu D., Lü X., Torten J., Ashley R.L., Cloyd M.W., and Miller C.J. Occult systemic infection and persistent SIV-specific CD4+ T cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J. Virol. 72 (1998) 10029-10035
36. Melchionda F., Fry T.J., Milliron M.J., McKirdy M.A., Tagaya Y., and Mackall C.L. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J. Clin. Invest. 115 (2005) 1177-1187
37. Mueller Y.M., Petrovas C., Bojczuk P.M., Dimitriou I.D., Beer B., Silvera P., Villinger F., Cairns J.S., Gracely E.J., Lewis M.G., and Katsikis P.D. Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques. J. Virol. 79 (2005) 4877-4885
38. Mueller Y.M., Do D.H., Altork S.R., Artlett C.M., Gracely E.J., Katsetos C.D., Legido A., Villinger F., Altman J.D., Brown C.R., Lewis M.G., and Katsikis P.D. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J. Immunol. 180 (2008) 350-360
39. Musey L., Hughes J., Schacker T., Shea T., Corey L., and McElrath M.J. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337 (1997) 1267-1274
40. Ogg G.S., Jin X., Bonhoeffer S., Dunbar P.R., Nowak M.A., Monard S., Segal J.P., Cao Y., Rowland-Jones S.L., Cerundolo V., Hurley A., Markowitz M., Ho D.D., Nixon D.F., and McMichael A.J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279 (1998) 2103-2106
41. Oh S., Berzofsky J.A., Burke D.S., Waldmann T.A., and Perera L.P. Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3392-3397
42. Oh S., Perera L.P., Terabe M., Ni L., Waldmann T.A., and Berzofsky J.A. IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 5201-5206
43. Picker L.J., Reed-Inderbitzin E.F., Hagen S.I., Edgar J.B., Hansen S.G., Legasse A., Planer S., Piatak M.J., D. L.J., Maino V.C., Axthelm M.K., and Villinger F. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J. Clin. Invest. 116 (2006) 1514-1524
44. Precopio M.L., Betts M.R., Parrino J., Price D.A., Gostick E., Ambrozak D.R., Asher T.E., Douek D.C., Harari A., Pantaleo G., Bailer R., Graham B.S., Roederer M., and Koup R.A. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204 (2007) 1405-1416
45. Priddy F.H., Brown D., Kublin J., Monahan K., Wright D.P., Lalezari J., Santiago S., Marmor M., Lally M., Novak R.M., Brown S.J., Kulkarni P., Dubey S.A., Kierstead L.S., Casimiro D.R., Mogg R., DiNubile M.J., Shiver J.W., Leavitt R.Y., Robertson M.N., Mehrotra D.V., and Quirk E. Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. Clin. Infect. Dis. 46 (2008) 1769-1781
46. Robert-Guroff M. Replicating and non-replicating viral vectors for vaccine development. Curr. Opin. Biotechnol. 374 (2007) 322-337
47. Sarkar S., Kalia V., Haining W.N., Konieczny B.T., Subramaniam S., and Ahmed R. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205 (2008) 625-640
48. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., and Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 (1999) 857-860
49. Shacklett B.L., Shaw K.E., Adamson L.A., Wilkens D.T., Cox C.A., Montefiori D.C., Gardner M.B., Sonigo P., and Luciw P.A. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251. J. Virol. 76 (2002) 11365-11378
50. Sparger E.E., Dubie R.A., Shacklett B.L., Cole K.S., Chang W.L., and Luciw P.A. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine. Virology 374 (2008) 261-272
51. Surh C.D., and Sprent J. Regulation of naïve and memory T-cell homeostasis. Microbes Infect. 4 (2002) 51-56
52. Surh C.D., Boyman O., Purton J.F., and Sprent J. Homeostasis of memory T cells. Immunol. Rev. 211 (2006) 154-163
53. Tavel J.A., Martin J.E., Kelly G.G., Enama M.E., Shen J.M., Gomez P.L., Andrews C.A., Koup R.A., Bailer R.T., Stein J.A., Roederer M., Nabel G.J., and Graham B.S. Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects. J. Acquir. Immune Defic. Syndr. 44 (2007) 601-605
54. Ulmer J.B., Wahren B., and Liu M.A. Gene-based vaccines: recent technical and clinical advances. Trends Mol. Med. 12 (2000) 216-222
55. Villinger F., Brar S.S., Mayne A., Chikkala N., and Ansari A.A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155 (1995) 3946-3954
56. Villinger F., Miller R., Mori K., Mayne A.E., Bostik P., Sundstrom J.B., Sugimoto C., and Ansari A.A. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 22 (2004) 3510-3521
57. Waldmann T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev., Immunol. 6 (2006) 595-601
58. Waldmann T.A., Dubois S., and Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14 (2001) 105-110
59. Wallace D.L., Bérard M., Soares M.V., Oldham J., Cook J.E., Akbar A.N., Tough D.F., and Beverley P.C. Prolonged exposure of naïve CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 119 (2006) 243-253
60. Watkins D.I., Burton D.R., Kallas E.G., Moore J.P., and Koff W.C. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med. 14 (2008) 617-621
61. Yasutomi Y., Reimann K.A., Lord C.I., Miller M.D., and Letvin N.L. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67 (1993) 1707-1711
62. Yin J., Dai A., Kutzler M.A., Shen A., Lecureux J., Lewis M.G., Waldmann T., Weiner D.B., and Boyer J.D. Sustained suppression of SHIV89.6P replication in macaques by vaccine-induced CD8+ memory T cells. AIDS 22 (2008) 1739-1748
63. Zhang W., Dong S.F., Sun S.H., Wang Y., Li G.D., and Qu D. Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen. World J. Gastroenterol. 12 (2006) 4727-4735
64. Zou J.X., and Luciw P.A. The requirement for Vif of SIVmac is cell-type dependent. J. Gen. Virol. 77 (1996) 427-434